PBM reform, Medicare Advantage exits, and the 340B rebate pilot are reshaping drug access. Here is what payers need to know heading into 2027.
|Articles|May 17, 2012
Healthcare Reform: GOP Preps Plan for Ruling on Law
Advertisement
House Republican leaders are quietly hatching a plan of attack as they await a historic Supreme Court ruling on President Barack Obama’s health care law.
If the law is upheld, Republicans will take to the floor to tear out its most controversial pieces, such as the individual mandate and requirements that employers provide insurance or face fines.
Read the full story:
Source: Politico
Advertisement
Related to this article
The 2026 meeting in Denver features more than 265 hours of programming, real-world MASH treatment data, and late-breaking results in rare liver diseases.
In 299 patients, more involved compartments were linked to higher complication risk after one-stage resection; 14.4% had documented recurrence.
A cranberry supplement was tied to greater OAB symptom score reductions than placebo in a 25-woman pilot trial, but urobiome findings were unconfirmed.
A runner's death at the NYC marathon highlights how heat, dehydration, illness, drugs, and genetics can raise exertional rhabdomyolysis risk.
ALLEGRO extension news shows Litfulo (ritlecitinib) delivers durable hair regrowth in severe alopecia areata after 3 years.
The GOLD International COPD Conference will cover underdiagnosis, exacerbations, mucus, biologics, and a preview of the 2027 GOLD Report.
People with multiple sclerosis make up most of a survey linking variable-friction footwear to fewer self-reported falls.
Advertisement
Advertisement
Trending on AJMC
1
NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus
2
Policy, AI, and High-Cost Therapies Shape AMCP Nexus 2026 Discussions
3
Ritlecitinib Sustains Hair Regrowth in Alopecia Areata Through 3 Years
4
Real-World Evidence, Rare Liver Disease Data Headline Kidney Week 2026
5